These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 396660)
1. Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects. Bianchi Porro G; Prada A; Petrillo M; Grossi M Scand J Gastroenterol Suppl; 1979; 57():63-7. PubMed ID: 396660 [TBL] [Abstract][Full Text] [Related]
2. Pirenzepine in the treatment of duodenal ulcer. D'Imperio N; Giuliani Piccari G; Lepore AM; Sarti F; Dal Monte PR Scand J Gastroenterol Suppl; 1979; 57():41-4. PubMed ID: 396656 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, short-term clinical trial of pirenzepine in duodenal ulcer. Morelli A; Narducci F; Pelli MA; Spadacini A Scand J Gastroenterol Suppl; 1979; 57():45-9. PubMed ID: 396657 [TBL] [Abstract][Full Text] [Related]
4. Pirenzepine versus cimetidine in the treatment of duodenal ulcer. Bianchi Porro G; Petrillo M; Lazzaroni M; Dal Monte PR; D'Imperio N; Giuliani Piccari G Scand J Gastroenterol Suppl; 1979; 57():59-62. PubMed ID: 396659 [TBL] [Abstract][Full Text] [Related]
5. Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial, First of two parts. Barbara L; Belsasso E; Bianchi Porro G; Blasi A; Caenazzo E; Chierichetti SM; Di Febo G; Di Mario F; Farini R; Giorgi-Conciato M; Grossi E; Mangiameli A; Miglioli M; Naccarato R; Petrillo M Scand J Gastroenterol Suppl; 1979; 57():11-5. PubMed ID: 396651 [TBL] [Abstract][Full Text] [Related]
6. Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial. Second of two parts. Barbara L; Belsasso E; Bianchi Porro G; Blasi A; Caenazzo E; Di Febo G; Di Mario F; Farini R; Giorgi-Conciato M; Mangiameli A; Miglioli M; Naccarato R; Petrillo M Scand J Gastroenterol Suppl; 1979; 57():17-9. PubMed ID: 396652 [TBL] [Abstract][Full Text] [Related]
7. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial. Oselladore D; Chierichetti SM; Norberto L; Vibelli C Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655 [TBL] [Abstract][Full Text] [Related]
8. Maintenance treatment of recurrent duodenal ulceration with pirenzepine. Petrillo M; Bianchi Porro G Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360 [TBL] [Abstract][Full Text] [Related]
9. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients. Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149 [TBL] [Abstract][Full Text] [Related]
10. Pirenzepine in the treatment of gastric ulcer. A double-blind short-term clinical trial. Morelli A; Pelli A; Narducci F; Spadacini A Scand J Gastroenterol Suppl; 1979; 57():51-5. PubMed ID: 396658 [TBL] [Abstract][Full Text] [Related]
11. The effect of pirenzepine on basal, pentagastrin- and insulin-stimulated gastric acid secretion in patients with peptic ulcer disease. Jaup BH; Stockbrügger R; Dotevall G Scand J Gastroenterol; 1979; 14(5):621-4. PubMed ID: 493866 [TBL] [Abstract][Full Text] [Related]
12. The influence of various secretory inhibitors on peptic activity. Gabryelewicz A; Laszewicz W; Sarosiek J Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587 [TBL] [Abstract][Full Text] [Related]
13. Influence of intravenous pirenzepine on gastric acid and pepsin in man. el-Sabbagh HN; Prinz RA; Welbourn RB; Baron JH Scand J Gastroenterol Suppl; 1980; 66():73-7. PubMed ID: 6787694 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a defective inhibition of pentagastrin-stimulated gastric acid secretion by antral distension in the duodenal ulcer patient. Schöön IM; Bergegårdh S; Grötzinger U; Olbe L Gastroenterology; 1978 Sep; 75(3):363-7. PubMed ID: 680489 [TBL] [Abstract][Full Text] [Related]
15. Treatment and relapse prophylaxis of duodenal ulcer with pirenzepine and cimetidine. Eichenberger PM; Giger M; Mattle W; Pelloni S; Müller-Lissner SA; Gonvers JJ; Birchler R; Blum AL Scand J Gastroenterol Suppl; 1982; 72():197-205. PubMed ID: 6753114 [TBL] [Abstract][Full Text] [Related]
16. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study. Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128 [TBL] [Abstract][Full Text] [Related]
17. Pirenzepine in the treatment of benign gastroduodenal diseases. A double-blind controlled clinical trial. Gasbarrini G; Giorgi-Conciato M; D'Anchino M; Di Tommaso B; Pesa O; Sollecito A; Cifani G Scand J Gastroenterol Suppl; 1979; 57():25-31. PubMed ID: 396654 [TBL] [Abstract][Full Text] [Related]
18. The effect of different doses of pirenzepine on gastric secretion stimulated by modified shamfeeding in man. Stockbrügger RW; Jaup BH; Dotevall G Scand J Gastroenterol Suppl; 1982; 72():111-7. PubMed ID: 6957978 [TBL] [Abstract][Full Text] [Related]
19. The effect of intragastric pH-variations on the gastric acid response to insulin hypoglycaemia in healthy subjects and duodenal ulcer patients. Stenquist B; Knutson U; Rehnberg O; Olbe L Scand J Gastroenterol; 1977; 12(2):169-75. PubMed ID: 15311 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease. Mahachai V; Reilly P; Thomson AB Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]